Mechanism of Isoniazid‐Induced Hepatotoxicity: Academic Case.
M.D- Departamento de Ginecología Clínica, Camilo García Espada, Clínica Nuestra Señora de Los Remedios- Valle del Cauca- Universidad Libre seccional Cali, Colombia., Kevin Oswaldo Urbano, M.D- Departamento de Ginecología Clínica; Clínica Nuestra Señora de Los Remedios- Valle del Cauca- Universidad Libre seccional Cali, Colombia., Alejandro Castillo, M.D- Departamento de Ginecología Clínica; Clínica Nuestra Señora de Los Remedios- Valle del Cauca- Universidad Libre seccional Cali, Colombia., Aura Lizeth Bastidas Mora, et al. (17 authors)
International Journal of Medical Science and Clinical Research Studies · 2024-06
Abstract
Isoniazid is used to treat or prophylaxis tuberculosis; However, its use may be associated with adverse liver reactions. Clinically overt hepatitis occurs in 0.5%-1% of patients receiving isoniazid as monotherapy. This clinical case reported allows the academy to always verify and monitor liver function in those who have medications that cause damage to liver cells.
MeSH terms
- Isoniazid
- Medicine
- Hepatitis
- Tuberculosis
- Liver function
- Adverse effect
- Liver function tests
- Mechanism (biology)
- Liver damage
- Toxic hepatitis
- Pharmacology
- Intensive care medicine
- Internal medicine